Dong-A Makes Deal For Darbepoetin Alfa With Turkey’s Polifarma

Biosimilar Version Of Aranesp/Nesp Licensed For Turkey, Brazil And Mexico

Korean developer Dong-A has signed an exclusive licensing deal with Turkey’s Polifarma covering its darbepoetin biosimilar version of Aranesp/Nesp in Turkey, Brazil and Mexico.

Turkey flag
Polifarma’s Home Of Turkey is one of the three countries covered by the agreement • Source: Shutterstock

Korean biosimilars developer Dong-A ST has signed a licensing deal with Turkey’s Polifarma offering exclusive rights to its Aranesp/Nesp (darbepoetin biosimilar) biosimilar, DA-3880, in Turkey, Brazil and Mexico.

Dong-A said the deal formed part of its efforts aimed at “building a foundation for expanding its biosimilar business through...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business